EMERALD MUTUAL FUND ADVISERS TRUST - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 128 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
EMERALD MUTUAL FUND ADVISERS TRUST ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2013$15,830,000
+365.6%
446,824
+105.2%
1.09%
+89.9%
Q2 2013$3,400,000–217,792–0.58%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2013
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders